Inah Yoon

Inah Yoon

Auto-generated profile, based on publicly available information

Inah Yoon

Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
BKBo Young Kim
Bo Young Kim
IYInah Yoon
Inah Yoon
SHSeong John Han
Seong John Han
SHSuk-Kyung Hong
Suk-Kyung Hong
SCSehoon Choi
Sehoon Choi
EKEun Key Kim
Eun Key Kim
Kim BY, et al. Ann Surg Treat Res. 2023 Oct;105(4):188-197. https://doi.org/10.4174/astr.2023.105.4.188

1 December 2022 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Open access
YKYoung Chul Kim
Young Chul Kim
IYIn Ah Yoon
In Ah Yoon
SWSoo Hyun Woo
Soo Hyun Woo
DSDong Ryul Song
Dong Ryul Song
KKKi Young Kim
Ki Young Kim
JCJong Woo Choi
Jong Woo Choi
This study aimed to demonstrate the in vitro performance of a novel polymer-ceramic composite incorporating polycaprolactone (PCL) and bioactive glass (BGS-7), and investigate its clinical outcomes in craniofacial reconstruction. After preparation of the material, the biochemical properties of the composite PCL/BGS-7 implant were tested to evaluate apatite formation in simulated body fluid (SBF). Changes in the implant surface after soaking in the SBF were determined using field-emission scanning electron microscopy. For clinical application of the implant, patients with craniofacial defects were prospectively enrolled to receive three-dimensional (3D)-printed PCL/BGS-7 implants. Clinical outcomes were investigated by reviewing postoperative complications, including wound problems, allergic responses, hematoma, seroma, implant displacement, and bone union. The accuracy of reconstruction was assessed by measuring the surface error between the reconstructed and mirrored models. Upon exposure of the PCL/BGS-7 implant to SBF, apatite particles were actively developed on the surface of the PCL/BGS-7 sample, showing favorable bone-binding capacity. Regarding the clinical application, seven patients with craniofacial defects were included. The clinical outcome was favorable in terms of complications, except in one patient, who presented with delayed wound healing due to previous irradiation. The patients showed improvements in symmetry, with a significant change in mean ± SD surface error between preoperative (5 ± 3 mm) and postoperative (1.5 ± 0.65 mm) status (p = 0.018). Wthin the limitations of the study it seems that the PCL/BGS-7 implants might be a relevant option for repairing craniofacial bone defects, owing to its favorable bone-binding property and clinical safety, with few complications.

30 October 2023 in Archives of Plastic Surgery
Verified
Journal Article
Open access
PDF file
IYInah Yoon
Inah Yoon
HKHyung Bae Kim
Hyung Bae Kim
JCJeongmok Cho
Jeongmok Cho
CPChangsik John Pak
Changsik John Pak
HSHyunsuk Peter Suh
Hyunsuk Peter Suh
JHJoon Pio Hong
Joon Pio Hong
The mammalian target of rapamycin (mTOR) inhibitors are used to prevent organ transplant rejection and are preferred over other immunosuppressants due to its low nephrotoxicity. However, mTOR inhibitors have been associated with various adverse effects including lymphedema. Although rare in incidence, previously known treatments for mTOR inhibitor-induced lymphedema were limited to discontinuation of related drugs and complex disruptive therapy with variable results.In this article, three patients who developed lymphedema in their lower limbs after using mTOR inhibitors, including two bilateral and one unilateral case, were treated with physiologic surgery methods such as lymphovenous anastomosis (LVA) and lymph node transfer. The efficacy of the treatment was evaluated.In the three cases described, cessation of the drug did not lead to any reduction in edema. The use of LVA and lymph node transfer resulted in early reductions in volume but failed to sustain over time. All patients underwent secondary nonphysiologic surgery such as liposuction resulting in sustained improvement.This series presents the first physiologic approach to mTOR inhibitor-induced lymphedema. Although further study is warranted, the physiologic surgical options may have limited success and nonphysiologic options may offer better sustainable results.

30 July 2022 in Archives of Aesthetic Plastic Surgery
Verified
Journal Article
Open access
PDF file
KMKyunghyun Min
Kyunghyun Min
IYInah Yoon
Inah Yoon
EKEun Key Kim
Eun Key Kim
Postmastectomy pain syndrome (PMPS) is defined as chronic pain lasting more than 3 months after surgery. PMPS reduces the quality of life for patients and affects their daily life. Although the pathogenesis of PMPS has not been clearly elucidated, it is strongly suggestive of neuropathic pain caused by damage to the intercostobrachial nerve. While previous studies have used stromal vascular fraction (SVF)-enriched fat grafts in patients with neuralgia, few studies have used it for PMPS. Therefore, the present study evaluated the use of SVF-enriched fat, which includes adipose-derived stem cells with good differentiation capacity, in patients with PMPS to improve quality of life and reduce neuropathic pain. In three patients, the fat was mixed with concentrated SVF using a centrifuge and injected into the primary pain sites. After surgery, in all three cases, the subjective pain scale score decreased significantly over time.